“…It is worth mentioning that among the most successful biocatalytic attempts are the lipase-catalyzed kinetic resolutions (KRs) of the respective racemates. In the last two decades, numerous highly efficient lipase-supported methods towards common non-racemic β-blockers, such as acebutolol, 7 alprenolol, 8 atenolol, 9 bufuralol, 10 bunitrolol, 11 carteolol, 12 carvedilol, 13 cloranolol, 14 esmolol, 15 labetalol, 16 metoprolol, 17 moprolol, 18 nifenalol, 19 pindolol, 20 practolol, 21 propranolol, 22 and satolol 22 b were elaborated. Despite these creative efforts invested in the biocatalytic syntheses of non-racemic β-blockers, the reported methods lack generality since any selected API of this class requires an independent and strictly dedicated synthetic strategy.…”